The p38 MAP kinase pathway as a therapeutic target in inflammatory disease

Current Opinion in Pharmacology

Volumn 4, Issue 4, 2004, Pages 372-377

  Saklatvala, Jeremy ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; ADENINE; AMG 548; ANTIINFLAMMATORY AGENT; ARQ 101; CD4 ANTIGEN; CDP 146; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; DORAMAPIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SB 681323; SCIO 323; SCIO 469; SD 341145; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; URACIL; VX 702; VX 850;

3' UNTRANSLATED REGION; ADENYLATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG SYNTHESIS; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 3342918498     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.03.009     Document Type: Review

References (55)

1. Lee J.C. Laydon J.T. McDonnell P.C. Gallagher T.F. Kumar S. Green D. McNulty D. Blumenthal M.J. Heys J.R. Landvatter S.W. et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739-746
2. Ono K. Han J. The p38 signal transduction pathway: activation and function Cell Signal 12 2000 1-13
3. Kumar S. Boehm J. Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Nat Rev Drug Discov 2 2003 717-726
4. Goedert M. Cuenda A. Craxton M. Jakes R. Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases EMBO J 16 1997 3563-3571
5. Hale K.K. Trollinger D. Rihanek M. Manthey C.L. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages J Immunol 162 1999 4246-4252
6. Kracht M. Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation Cytokine 20 2002 91-106
7. Clark A.R. Dean J.L. Saklatvala J. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38 FEBS Lett 546 2003 37-44
8. Lasa M. Abraham S.M. Boucheron C. Saklatvala J. Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38 Mol Cell Biol 22 2002 7802-7811
9. Wiggin G.R. Soloaga A. Foster J.M. Murray-Tait V. Cohen P. Arthur J.S. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts Mol Cell Biol 22 2002 2871-2881
10. Vermeulen L. De Wilde G. Damme P.V. Vanden Berghe W. Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1) Embo J 22 2003 1313-1324
11. Soloaga A. Thomson S. Wiggin G.R. Rampersaud N. Dyson M.H. Hazzalin C.A. Mahadevan L.C. Arthur J.S. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14 EMBO J 22 2003 2788-2797
12. Winzen R. Kracht M. Ritter B. Wilhelm A. Chen C.Y.A. Shyu A.B. Muller M. Gaestel M. Resch K. Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism EMBO J 18 1999 4969-4980
13. Lasa M. Mahtani K.R. Finch A. Brewer G. Saklatvala J. Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade Mol Cell Biol 20 2000 4265-4274
14. Kontoyiannis D. Pasparakis M. Pizarro T.T. Cominelli F. Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU- rich elements: implications for joint and gut-associated immunopathologies Immunity 10 1999 387-398
15. Bakheet T. Frevel M. Williams B.R. Greer W. Khabar K.S. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins Nucleic Acids Res 29 2001 246-254
16. Frevel M.A. Bakheet T. Silva A.M. Hissong J.G. Khabar K.S. Williams B.R. p38 mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts Mol Cell Biol 23 2003 425-436
17. Kotlyarov A. Neininger A. Schubert C. Eckert R. Birchmeier C. Volk H.D. Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis Nat Cell Biol 1 1999 94-97
18. Neininger A. Kontoyiannis D. Kotlyarov A. Winzen R. Eckert R. Volk H.D. Holtmann H. Kollias G. Gaestel M. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels J Biol Chem 277 2002 3065-3068
19. Kotlyarov A. Yannoni Y. Fritz S. Laass K. Telliez J.B. Pitman D. Lin L.L. Gaestel M. Distinct cellular functions of MK2 Mol Cell Biol 22 2002 4827-4835
20. Brook M. Sully G. Clark A.R. Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade FEBS Lett 483 2000 57-61
21. Rutault K. Hazzalin C.A. Mahadevan L.C. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts J Biol Chem 276 2001 6666-6674
22. Ridley S.H. Dean J.L. Sarsfield S.J. Brook M. Clark A.R. Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA FEBS Lett 439 1998 75-80
23. Dean J.L.E. Brook M. Clark A.R. Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J Biol Chem 274 1999 264-269
24. Sully G. Dean J.L. Wait R. Rawlirtson L. Santalucia T. Saklatvala J. Clark A.R. Structural and functional dissection of a conseved destabilizing element of cyclo-oxygenase-2 mRNA: eveidence against the involvement of AUF-1 [Au-rich element/poly (U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein1) Biochem J 377 2004 629-639
25. Dean J.L. Sarsfield S.J. Tsounakou E. Saklatvala J. p38 mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation J Biol Chem 278 2003 39470-39476
26. Scheper G.C. Proud C.G. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur J Biochem 269 2002 5350-5359
27. Freshney N.W. Rawlinson L. Guesdon F. Jones E. Cowley S. Hsuan J. Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27 Cell 78 1994 1039-1049
28. Mahtani K.R. Brook M. Dean J.L. Sully G. Saklatvala J. Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability Mol Cell Biol 21 2001 6461-6469
29. Chrestensen C.A. Schroeder M.J. Shabanowitz J. Hunt D.F. Pelo J.W. Worthington M.T. Sturgill T.W. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding J Biol Chem 279 2004 10176-10184
30. Taylor G.A. Carballo E. Lee D.M. Lai W.S. Thompson M.J. Patel D.D. Schenkman D.I. Gilkeson G.S. Broxmeyer H.E. Haynes B.F. et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency Immunity 4 1996 445-454
31. Lai W.S. Carballo E. Strum J.R. Kennington E.A. Phillips R.S. Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA Mol Cell Biol 19 1999 4311-4323
32. Carballo E. Cao H. Lai W.S. Kennington E.A. Campbell D. Blackshear P.J. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway J Biol Chem 276 2001 42580-42587
33. Stoecklin G. Stubbs T. Kedersha N. Wax S. Rigby W.F. Blackwell T.K. Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay EMBO J 23 2004 1313-1324
34. Lai W.S. Carballo E. Thorn J.M. Kennington E.A. Blackshear P.J. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA J Biol Chem 275 2000 17827-17837
35. Dean J.L. Wait R. Mahtani K.R. Sully G. Clark A.R. Saklatvala J. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR Mol Cell Biol 21 2001 721-730
36. Wilson G.M. Lu J. Sutphen K. Sun Y. Huynh Y. Brewer G. Regulation of A + U-rich element-directed mRNA turnover involving reversible phosphorylation of AUF1 J Biol Chem 278 2003 33029-33038
37. Dean J.L. Sully G. Wait R. Rawlinson L. Clark A.R. Saklatvala J. Identification of a novel AU-rich-element-binding protein which is related to AUF1 Biochem J 366 2002 709-719
38. Rousseau S. Morrice N. Peggie M. Campbell D.G. Gaestel M. Cohen P. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs EMBO J 21 2002 6505-6514
39. Bollig F. Winzen R. Gaestel M. Kostka S. Resch K. Holtmann H. Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization Biochem Biophys Res Commun 301 2003 665-670
40. Piecyk M. Wax S. Beck A.R. Kedersha N. Gupta M. Maritim B. Chen S. Gueydan C. Kruys V. Streuli M. et al. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha EMBO J 19 2000 4154-4163
41. Ridley S.H. Sarsfield S.J. Lee J.C. Bigg H.F. Cawston T.E. Taylor D.J. DeWitt D.L. Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels J Immunol 158 1997 3165-3173
42. Miyazawa K. Mori A. Miyata H. Akahane M. Ajisawa Y. Okudaira H. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase J Biol Chem 273 1998 24832-24838
43. Goebeler M. Kilian K. Gillitzer R. Kunz M. Yoshimura T. Brocker E.B. Rapp U.R. Ludwig S. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells Blood 93 1999 857-865
44. Feng G.J. Goodridge H.S. Harnett M.M. Wei X.Q. Nikolaev A.V. Higson A.P. Liew F.Y. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase J Immunol 163 1999 6403-6412
45. Reunanen N. Li S.P. Ahonen M. Foschi M. Han J. Kahari V.M. Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization J Biol Chem 277 2002 32360-32368
46. Kumar S. Votta B.J. Rieman D.J. Badger A.M. Gowen M. Lee J.C. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase J Cell Physiol 187 2001 294-303
47. Saklatvala J. Rawlinson L. Watter R.J. Sarsfield S. Lee J.C. Morton L.F. Barnes M.J. Farndale R.W. Role of p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue J Biol Chem 271 1996 6586-6589
48. Canobbio I. Reineri S. Sinigaglia F. Balduini C. Torti M. A role for p38 MAP kinase in platelet activation by von Willebrand factor Thromb Haemost 91 2004 102-110
49. Wang Y. Huang S. Sah V.P. Ross Jr. J. Brown J.H. Han J. Chien K.R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family J Biol Chem 273 1998 2161-2168
50. Alvarado-Kristensson M. Melander F. Leandersson K. Ronnstrand L. Wernstedt C. Andersson T. p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils J Exp Med 199 2004 449-458
51. Matsumoto M. Sudo T. Saito T. Osada H. Tsujimoto M. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL) J Biol Chem 275 2000 31155-31161
52. Jackson P.F. Bullington J.L. Pyridinylimidazole based p38 MAP kinase inhibitors Curr Top Med Chem 2 2002 1011-1020
53. Cirillo P.F. Pargellis C. Regan J. The non-diaryl heterocycle classes of p38 MAP kinase inhibitors Curr Top Med Chem 2 2002 1021-1035
54. Pargellis C. Tong L. Churchill L. Cirillo P.F. Gilmore T. Graham A.G. Grob P.M. Hickey E.R. Moss N. Pav S. et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site Nat Struct Biol 9 2002 268-272
55. Pargellis C. Regan J. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis Curr Opin Investig Drugs 4 2003 566-571